Table 4.
Sequencing of 5 peritumoral kidney specimens of the validation collection screened with BMMF2/Sphinx2.36-specific primers.
| Specific Primer | # | Sequence Results | Identity |
|---|---|---|---|
| BMMF2-FA1 | 1 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 99% |
| 2 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 99% | |
| 3 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 99% | |
| 4 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 99% | |
| 5 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 99% | |
| BMMF2-FA4 | 1 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 98% |
| 2 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 98% | |
| 3 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 98% | |
| 4 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 99% | |
| 5 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 98% | |
| BMMF2-FA7 | 1 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 99% |
| 2 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 98% | |
| 3 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 99% | |
| 4 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 98% | |
| 5 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 98% | |
| BMMF2-FA8 | 1 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 99% |
| 2 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 99% | |
| 3 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 99% | |
| 4 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 99% | |
| 5 | TSE-associated circular DNA isolate Sphinx 2.36, complete sequence | 99% |